DeepScaffold: a comprehensive tool for scaffold-based de novo drug discovery using deep learning
The ultimate goal of drug design is to find novel compounds with desirable pharmacological properties. Designing molecules retaining particular scaffolds as the core structures of the molecules is one of the efficient ways to obtain potential drug candidates with desirable properties. We proposed a scaffold-based molecular generative model for scaffold-based drug discovery, which performs molecule generation based on a wide spectrum of scaffold definitions, including BM-scaffolds, cyclic skeletons, as well as scaffolds with specifications on side-chain properties. The model can generalize the learned chemical rules of adding atoms and bonds to a given scaffold. Furthermore, the generated compounds were evaluated by molecular docking in DRD2 targets and the results demonstrated that this approach can be effectively applied to solve several drug design problems, including the generation of compounds containing a given scaffold and de novo drug design of potential drug candidates with specific docking scores. Finally, a command line interface is created.
Code (0)
등록된 구현이 없습니다.
Tasks
Drug DesignDrug DiscoveryMolecular DockingSimilar Papers 제목 키워드 기반
Scaffold-constrained molecular generation
One of the major applications of generative models for drug Discovery targets the lead-optimization phase. During the optimization of a lead series, it is common to have scaffold constraints imposed on the structure of t…
Drug DesignDrug DiscoveryCBGBench: Fill in the Blank of Protein-Molecule Complex Binding Graph
Structure-based drug design (SBDD) aims to generate potential drugs that can bind to a target protein and is greatly expedited by the aid of AI techniques in generative models. However, a lack of systematic understanding…
Drug DesignFairnessGenerative Active Learning for the Search of Small-molecule Protein Binders
Despite substantial progress in machine learning for scientific discovery in recent years, truly de novo design of small molecules which exhibit a property of interest remains a significant challenge. We introduce Lambda…
Active LearningDeep Reinforcement LearningMolecular Dockingscientific discoveryAccelerating Discovery of Novel and Bioactive Ligands With Pharmacophore-Informed Generative Models
Deep generative models have gained significant advancements to accelerate drug discovery by generating bioactive chemicals against desired targets. Nevertheless, most generated compounds that have been validated for pote…
Drug DiscoveryMulti-Objective De Novo Drug Design with Conditional Graph Generative Model
Recently, deep generative models have revealed itself as a promising way of performing de novo molecule design. However, previous research has focused mainly on generating SMILES strings instead of molecular graphs. Alth…
Drug Designvalid